Tradestie Institutional Equity Comparison Engine

RGNX vs VSTM โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

VSTM Overall Edge

VSTM Captures Institutional Edge (2โ€“2 Pillars ยท 5โ€“3 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Verastem, Inc. (VSTM) driven by superior Momentum & Technical, Options & Structure while RGNX counters with relative strength in Valuation, Growth & Margin. Fundamentally, RGNX trades at N/M Forward P/E with -120.4% operating margin (-69.2% YoY revenue) versus VSTM at N/M Forward P/E and -193.7% operating margin (+113.6% YoY). In options structure, RGNX sits in BREAKDOWN (52nd %ile IV; Dealer Gamma Walls on Pro) against VSTM sits in CONSOLIDATION (10th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner RGNX
RGNX N/M vs VSTM N/M Fwd P/E
Growth & Margin Winner RGNX
Op Margin -120.4% vs -193.7% ยท YoY -69.2% vs +113.6%
Momentum & Technical Winner VSTM
1Y -35.8% vs -2.8% ยท 52W Pos 19% vs 60%
Options & Structure Winner VSTM
BREAKDOWN (52nd %ile IV) vs CONSOLIDATION (10th %ile IV)
RGNX NASDAQ
REGENXBIO Inc.
Biological Products, (No Disgnostic Substances)
$7.47
-2.23% 1D
Market Cap $500.9M
1M Return +7.87%
1Y Return -35.82%
Forward P/E N/M
Unified AI Score
45.3 / 100 HOLD
Tech 36.0 Fund 44.0 Flow 69.0 Mom 50.0
VSTM NASDAQ
Verastem, Inc.
Pharmaceutical Preparations
$7.88
-3.67% 1D
Market Cap $1.1B
1M Return -8.9%
1Y Return -2.84%
Forward P/E N/M
Unified AI Score
56.9 / 100 HOLD
Tech 33.0 Fund 51.0 Flow 64.0 Mom 70.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: RGNX -35.82% VSTM -2.84% Spread: +32.98 pp (VSTM Lead)

Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period RGNX Revenue VSTM Revenue RGNX Op. Margin VSTM Op. Margin Margin Edge
FY2018 $220M $30M 40.3% -354.8% RGNX
FY2019 $40M $20M -422.9% -758.1% RGNX
FY2020 $150M $90M -77.1% -55.8% VSTM
FY2021 $470M $0M 34.0% -2991.2% RGNX
FY2022 $110M $0M -233.2% -2809.6% RGNX
FY2023 $90M N/A -297.1% N/A RGNX
FY2024 $80M $10M -280.0% -1149.6% RGNX
FY2025 $170M $30M -94.6% -550.3% RGNX

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: RGNX (3) vs VSTM (5)
Institutional Metric RGNX VSTM Criterion Row Winner
Market Capitalization Scale $500.9M $1.1B Larger Scale VSTM
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth -69.2% +113.6% Higher Growth VSTM
Operating Margin (TTM) Profitability -120.4% -193.7% Higher Margin RGNX
Net Profit Margin Profitability -113.9% -178.4% Higher Margin RGNX
Return on Equity (ROE) Capital Efficiency -113.2% -471.2% Higher ROE RGNX
52-Week Range Position Momentum 19% ($5โ€“$16) 60% ($3โ€“$11) Stronger Trend VSTM
Beta / 30D Volatility Risk Regime 1.81ฮฒ ยท 76% Vol 1.11ฮฒ ยท 71% Vol Lower Realized Risk VSTM
Unified Institutional Score Composite Signal 45.3 / 100 (HOLD) 56.9 / 100 (HOLD) Higher Composite VSTM

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full RGNX vs VSTM Buy Guide
RGNX BREAKDOWN
91d in phase ยท OBV ACCUMULATION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 52nd %ile
IV Regime Balanced (25thโ€“60th %ile)
Live RGNX Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
VSTM CONSOLIDATION
50d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 10th %ile
IV Regime Compressed (<25th %ile)
Live VSTM Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither RGNX nor VSTM registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.